{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:04:29Z","timestamp":1781701469990,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/03756-4"],"award-info":[{"award-number":["2015\/03756-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303422\/2015-7"],"award-info":[{"award-number":["303422\/2015-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305068\/2014-8"],"award-info":[{"award-number":["305068\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04798-6","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T18:02:53Z","timestamp":1573322573000},"page":"515-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching"],"prefix":"10.1007","volume":"39","author":[{"given":"Juliana Barbosa","family":"Brunelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis Almeida","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Gofinet","family":"Pasoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Gon\u00e7alves Schahin","family":"Saa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Tomie","family":"Kozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Goldenstein-Schainberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Pires","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete B. G.","family":"Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fontoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4348","authenticated-orcid":false,"given":"N\u00e1dia Emi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"issue":"10","key":"4798_CR1","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/rheumatology\/kez030","volume":"58","author":"Martijn J H Doeleman","year":"2019","unstructured":"Doeleman MJH, van Maarseveen EM, Swart JF (2019) Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kez030","journal-title":"Rheumatology"},{"issue":"8","key":"4798_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A (2008) Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359(8):810\u2013820. \nhttps:\/\/doi.org\/10.1056\/NEJMoa0706290","journal-title":"N Engl J Med"},{"issue":"5","key":"4798_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/03009742.2015.1022213","volume":"44","author":"A Skrabl-Baumgartner","year":"2015","unstructured":"Skrabl-Baumgartner A, Erwa W, Muntean W, Jahnel J (2015) Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response. Scand J Rheumatol 44(5):359\u2013362. \nhttps:\/\/doi.org\/10.3109\/03009742.2015.1022213","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"4798_CR4","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10067-018-4057-7","volume":"37","author":"A Marino","year":"2018","unstructured":"Marino A, Real-Fern\u00e1ndez F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G (2018) Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations. Clin Rheumatol 37(5):1407\u20131411. \nhttps:\/\/doi.org\/10.1007\/s10067-018-4057-7","journal-title":"Clin Rheumatol"},{"issue":"12","key":"4798_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10067-012-2082-5","volume":"31","author":"T Imagawa","year":"2012","unstructured":"Imagawa T, Takei S, Umebayashi H, Yamaguchi K, Itoh Y, Kawai T, Iwata N, Murata T, Okafuji I, Miyoshi M, Onoe Y, Kawano Y, Kinjo N, Mori M, Mozaffarian N, Kupper H, Santra S, Patel G, Kawai S, Yokota S (2012) Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clin Rheumatol 31(12):1713\u20131721. \nhttps:\/\/doi.org\/10.1007\/s10067-012-2082-5","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4798_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/acr.22657","volume":"67","author":"R Burgos-Vargas","year":"2015","unstructured":"Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, Unnebrink K, Anderson JK (2015) A randomized, double-blind, placebo-controlled multicenter study of adalimumab in pediatric patients with enthesitis-related arthritis. Arthritis Care Res 67(11):1503\u20131512. \nhttps:\/\/doi.org\/10.1002\/acr.22657","journal-title":"Arthritis Care Res"},{"issue":"6","key":"4798_CR7","first-page":"1043","volume":"35","author":"ST Leinonen","year":"2017","unstructured":"Leinonen ST, Aalto K, Kotaniemi KM, Kivel\u00e4 TT (2017) Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis. Clin Exp Rheumatol 35(6):1043\u20131046","journal-title":"Clin Exp Rheumatol"},{"key":"4798_CR8","first-page":"390","volume":"2","author":"RR Petty","year":"2004","unstructured":"Petty RR, Southwood T, Manners P, Baum J, Glass DN, Goldenber J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2:390\u2013392","journal-title":"J Rheumatol"},{"issue":"4 Suppl 23","key":"4798_CR9","first-page":"S25","volume":"19","author":"CS Machado","year":"2001","unstructured":"Machado CS, Ruperto N, Silva CH, Ferriani VP, Roscoe I, Campos LM, Oliveira SK, Kiss MH, Bica BE, Sztajnbok F, Len CA, Melo-Gomes JA, Paediatric Rheumatology International Trials Organisation (2001) The Brazilian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(4 Suppl 23):S25\u2013S29","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4798_CR10","first-page":"813","volume":"17","author":"MB Ferraz","year":"1990","unstructured":"Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P (1990) Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 17(6):813\u2013817","journal-title":"J Rheumatol"},{"issue":"5","key":"4798_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A, Paediatric Rheumatology International Trials Organisation (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658\u2013666. \nhttps:\/\/doi.org\/10.1002\/art.24516","journal-title":"Arthritis Rheum"},{"key":"4798_CR12","unstructured":"van Riel PL (2014) The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol 32(5 Suppl 85):S-65-74."},{"key":"4798_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7%3C1202::AID-ART3%3E3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202\u20131209. \nhttps:\/\/doi.org\/10.1002\/1529-0131(199707)40:7%3C1202::AID-ART3%3E3.0.CO;2-R","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4798_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 63(4):465\u2013482. \nhttps:\/\/doi.org\/10.1002\/acr.20460","journal-title":"Arthritis Care Res"},{"issue":"8","key":"4798_CR15","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/art.39169","volume":"67","author":"M Jani","year":"2015","unstructured":"Jani M, Chinoy H, Warren RB, Griffiths CE, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Barton A, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators (2015) Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis. Arthritis Rheum 67(8):2011\u20132019. \nhttps:\/\/doi.org\/10.1002\/art.39169","journal-title":"Arthritis Rheum"},{"issue":"2-3","key":"4798_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12016-009-8140-3","volume":"38","author":"N Emi Aikawa","year":"2010","unstructured":"Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, Bonf\u00e1 E (2010) Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol 38(2-3):82\u201389. \nhttps:\/\/doi.org\/10.1007\/s12016-009-8140-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"15","key":"4798_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamainternmed.2013.7430","volume":"173","author":"JR Maneiro","year":"2013","unstructured":"Maneiro JR, Salgado E, Gomez-Reino JJ (2013) Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis. JAMA Intern Med 173(15):1416\u20131428. \nhttps:\/\/doi.org\/10.1001\/jamainternmed.2013.7430","journal-title":"JAMA Intern Med"},{"issue":"4","key":"4798_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40259-015-0134-5","volume":"29","author":"SS Thomas","year":"2015","unstructured":"Thomas SS, Borazan N, Barroso N, Duan L, Taroumian S, Kretzmann B, Bardales R, Elashoff D, Vangala S, Furst DE (2015) Comparative immunogenicity of TNF inhibitors: impact on clinical efficacy and tolerability in the management of autoimmune diseases. A Systematic Review and Meta-Analysis. BioDrugs 29(4):241\u2013258. \nhttps:\/\/doi.org\/10.1007\/s40259-015-0134-5","journal-title":"BioDrugs"},{"issue":"3","key":"4798_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10067-018-4355-0","volume":"38","author":"A Mart\u00ednez-Feito","year":"2019","unstructured":"Mart\u00ednez-Feito A, Plasencia-Rodr\u00edguez C, Navarro-Comp\u00e1n V, Hern\u00e1ndez-Breijo B, Gonz\u00e1lez M\u00c1, Monjo I, Nu\u00f1o L, Nozal P, Pascual-Salcedo D, Balsa A (2019) The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. Clin Rheumatol 38(3):949\u2013954. \nhttps:\/\/doi.org\/10.1007\/s10067-018-4355-0","journal-title":"Clin Rheumatol"},{"key":"4798_CR20","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.3389\/fimmu.2018.03168","volume":"9","author":"SA Mahmud","year":"2019","unstructured":"Mahmud SA, Binstadt BA (2019) Autoantibodies in the pathogenesis, diagnosis, and prognosis of juvenile idiopathic arthritis. Front Immunol 9:3168. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.03168","journal-title":"Front Immunol"},{"issue":"10","key":"4798_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10067-013-2336-x","volume":"32","author":"CC Mok","year":"2013","unstructured":"Mok CC, van der Kleij D, Wolbink GJ (2013) Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNF\u03b1 biologics in rheumatic diseases. Clin Rheumatol 32(10):1429\u20131435. \nhttps:\/\/doi.org\/10.1007\/s10067-013-2336-x","journal-title":"Clin Rheumatol"},{"key":"4798_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-017-8642-3","volume":"56","author":"M Cattalini","year":"2017","unstructured":"Cattalini M, Soliani M, Caparello MC, Cimaz R (2017) Sex differences in pediatric rheumatology. Clin Rev Allergy Immunol 56:293\u2013307. \nhttps:\/\/doi.org\/10.1007\/s12016-017-8642-3","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04798-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:50:10Z","timestamp":1604796610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4798"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04798-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"27 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}